Gemigliptin L-tartrate Sesquihydrate |
LC-150444; LC-15-0444 |
Approved |
Lg Life Sciences Ltd |
Gemiglo, Zemiglo |
South Korea |
Diabetes Mellitus, Type 2 |
Lg Life Sciences Ltd |
2012-06-27 |
Diabetes Mellitus, Type 2; Hepatic Insufficiency |
Details
|
Gemigliptin L-tartrate Sesquihydrate/Metformin Hydrochloride |
|
Approved |
Lg Life Sciences Ltd |
ZemiMet SR |
South Korea |
Diabetes Mellitus, Type 2 |
Lg Life Sciences Ltd |
2015-01-01 |
Diabetes Mellitus, Type 2 |
Details
|
Teneligliptin Hydrobromide Hydrate/Metformin Hydrochloride |
|
Approved |
Handok Inc |
Tenelia M SR |
South Korea |
Diabetes Mellitus, Type 2 |
Handok Inc |
2015-11-03 |
Diabetes Mellitus, Type 2 |
Details
|
Evogliptin |
DA-1229 |
Approved |
Dong-A Pharmaceutical Co Ltd |
Suganon, Sugarnon |
South Korea |
Diabetes Mellitus, Type 2 |
Dong-A Pharmaceutical Co Ltd |
2015-10-02 |
Diabetes Mellitus, Type 2; Kidney Diseases; Aortic valve diseases; Liver Diseases |
Details
|
Saxagliptin Hydrate |
BMS-477118; BMS-477118-11; OPC-262 |
Approved |
Bristol-Myers Squibb Company |
安立泽, Onglyza |
EU |
Diabetes Mellitus, Type 2 |
Astrazeneca Ab |
2009-07-31 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Hypoglycemia; Diabetes Mellitus |
Details
|
Teneligliptin Hydrobromide Hydrate |
MP-513 |
Approved |
Mitsubishi Tanabe Pharma |
Tenelia, Tenglyn |
Japan |
Diabetes Mellitus, Type 2 |
Mitsubishi Tanabe Pharma, Daiichi Sankyo Co Ltd |
2012-06-29 |
Diabetes Mellitus, Type 2 |
Details
|
Retagliptin Phosphate |
SP-2086 Phosphate |
Approved |
Jiangsu Hengrui Medicine Co Ltd |
瑞泽唐 |
Mainland China |
Diabetes Mellitus, Type 2 |
Jiangsu Hengrui Medicine Co Ltd |
2023-06-27 |
Diabetes Mellitus, Type 2; Renal Insufficiency; Diabetes Mellitus |
Details
|
Sitagliptin Phosphate Monohydrate/Ipragliflozin L-Proline |
MK-0431J |
Approved |
Merck & Co Inc, Astellas Pharma Inc |
Sujanu |
Japan |
Diabetes Mellitus, Type 2 |
null |
2018-03-23 |
Diabetes Mellitus, Type 2 |
Details
|
Linagliptin |
BI-1356; BI-1356-BS |
Approved |
Boehringer Ingelheim Gmbh |
欧唐宁, Ondero, Trajenta, Trayenta, Trazenta, Tradjenta |
United States |
Diabetes Mellitus, Type 2 |
Boehringer Ingelheim Gmbh |
2011-05-02 |
Prediabetic State; Diabetes Mellitus, Type 2; Albuminuria; Renal Insufficiency; Schizophrenia; Respiratory Tract Diseases; Coronavirus Disease 2019 (COVID-19); Hypertension; Endocrine System Diseases; Coronavirus Infections; Metabolic Diseases; Hepatic Insufficiency; Glucose Metabolism Disorders; Inflammation; Diabetes Mellitus; Ventricular Dysfunction, Left |
Details
|
Rosuvastatin Calcium/Gemigliptin L-tartrate Sesquihydrate |
|
Approved |
Lg Life Sciences Ltd |
ZemiStatin |
|
|
|
|
Diabetes Mellitus, Type 2; Dyslipidemias |
Details
|
Alogliptin Benzoate |
SYR-322; TAK-322 |
Approved |
Takeda |
Nesina, 尼欣那, Vipidia |
Japan |
Diabetes Mellitus, Type 2 |
Takeda |
2010-04-06 |
Diabetes Mellitus, Type 2; Acute Coronary Syndrome; Diabetes Mellitus |
Details
|
Empagliflozin/Linagliptin/Metformin |
|
Approved |
Boehringer Ingelheim Gmbh, Eli Lilly And Company |
Trijardy XR |
United States |
Diabetes Mellitus, Type 2 |
Boehringer Ingelheim Gmbh |
2020-01-27 |
Diabetes Mellitus, Type 2 |
Details
|
Sitagliptin Phosphate/Metformin Hydrochloride |
|
Approved |
Merck & Co Inc |
Velmetia, Janumet, 捷诺达, Zituvimet |
United States |
Diabetes Mellitus, Type 2 |
Merck & Co Inc |
2007-03-30 |
Diabetes Mellitus, Type 2 |
Details
|
Teneligliptin Hydrobromide Hydrate/Canagliflozin Hemihydrate |
|
Approved |
Mitsubishi Tanabe Pharma Corp, Daiichi Sankyo Co Ltd |
Canalia |
Japan |
Diabetes Mellitus, Type 2 |
Daiichi Sankyo Co Ltd, Mitsubishi Tanabe Pharma |
2017-07-03 |
Diabetes Mellitus, Type 2 |
Details
|
Anagliptin/Metformin Hydrochloride |
SK-1501 |
Approved |
Sanwa Kagaku Kenkyusho Co Ltd, Suzuken |
Metoana |
Japan |
Diabetes Mellitus, Type 2 |
Sanwa Kagaku Kenkyusho Co Ltd |
2018-09-21 |
Diabetes Mellitus, Type 2 |
Details
|
Vildagliptin/Metformin Hydrochloride |
LMF-237 |
Approved |
Novartis Pharma Ag |
宜合瑞, Eucreas, EquMet, Zomarist, Icandra |
EU |
Diabetes Mellitus, Type 2 |
Novartis Europharm Ltd |
2007-11-14 |
Diabetes Mellitus, Type 2 |
Details
|
Alogliptin Benzoate/Metformin Hydrochloride |
CT-L01; CT-L-01 |
Approved |
Takeda Pharmaceutical Co Ltd |
Vipdomet, Inisync, Kazano |
United States |
Diabetes Mellitus, Type 2 |
Takeda Pharmaceuticals U.S.A. Inc |
2013-01-25 |
Diabetes Mellitus, Type 2 |
Details
|
Anagliptin |
SK-0403; CWP-0403 |
Approved |
Sanwa Kagaku Kenkyusho Co Ltd |
Suiny, Beskoa |
Japan |
Diabetes Mellitus, Type 2 |
null |
2012-09-28 |
Diabetes Mellitus, Type 2 |
Details
|
Dapagliflozin Propanediol Monohydrate/Saxagliptin Hydrochloride |
|
Approved |
Astrazeneca Plc |
Qtern |
EU |
Diabetes Mellitus, Type 2 |
Astrazeneca Ab |
2016-07-15 |
Diabetes Mellitus, Type 2 |
Details
|
Alogliptin Benzoate/Pioglitazone Hydrochloride |
SYR-322-4833 BL |
Approved |
Takeda Pharmaceutical Co Ltd |
Nesinaact, Oseni, Liovel, Incresync |
Japan |
Diabetes Mellitus, Type 2 |
Takeda |
2011-07-01 |
Diabetes Mellitus, Type 2 |
Details
|
Sitagliptin Phosphate Monohydrate |
ONO-5435A; ONO-5435; MK-0431; MK-431; L-000224715 |
Approved |
Merck Sharp & Dohme Corp |
Ristaben, Xelevia, Tesavel, Glactiv, 捷诺维, Januvia, DIABIT-IS X |
United States |
Diabetes Mellitus, Type 2 |
Merck & Co Inc |
2006-10-16 |
Gastroparesis; Carcinoma, Hepatocellular; Hyperlipidemias; Kidney Failure, Chronic; Diabetes Mellitus; Inflammation; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Renal Insufficiency, Chronic; Cardiovascular Diseases; Hepatic Insufficiency; Hepatitis C; Psoriasis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Cystic Fibrosis; Insulin Resistance; Coronavirus Disease 2019 (COVID-19); Myelodysplastic Syndromes; Graft vs Host Disease; Glucose Intolerance; Atherosclerosis; Metabolic Dysfunction-Associated Steatotic Liver Disease; Diabetes Mellitus, Type 2; Heart Failure; HIV Infections; Prediabetic State; Diabetes Mellitus, Type 1; Leukemia, Myelogenous, Chronic |
Details
|
Trelagliptin Succinate |
TAK-472; SYR-472; SYR-111472; SYR-111472 succinate |
Approved |
Takeda Pharmaceutical Co Ltd |
Zafatek |
Japan |
Diabetes Mellitus, Type 2 |
Takeda |
2015-03-26 |
Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Evogliptin Tartrate/Metformin Hydrochloride |
DA-1229_01 |
Approved |
Dong-A Pharmaceutical Co Ltd |
Sugamet XR |
South Korea |
Diabetes Mellitus, Type 2 |
Dong-A Pharmaceutical Co Ltd |
2015-12-01 |
Diabetes Mellitus, Type 2 |
Details
|
Sitagliptin/Ertugliflozin |
|
Approved |
Pfizer Inc |
Steglujan |
United States |
Diabetes Mellitus, Type 2 |
Merck & Co Inc |
2017-12-19 |
Diabetes Mellitus, Type 2 |
Details
|
Omarigliptin |
MK-3102 |
Approved |
Merck & Co Inc |
Marizev |
Japan |
Diabetes Mellitus, Type 2 |
Merck Sharp & Dohme Corp |
2015-09-28 |
Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic; Diabetes Mellitus |
Details
|
Teneligliptin/Pioglitazone |
|
Approved |
Glenmark Pharmaceuticals Ltd |
Zita Plus Pio |
India |
Diabetes Mellitus, Type 2 |
Glenmark Pharmaceuticals Ltd |
2022-04-25 |
Diabetes Mellitus, Type 2 |
Details
|
Metformin Hydrochloride/Sitagliptin Hydrochloride |
|
Approved |
Sandoz Bv |
|
EU |
|
Sandoz Bv |
2019-12-10 |
Diabetes Mellitus, Type 2 |
Details
|
Sitagliptin Tartrate |
|
Approved |
Heumann Pharma GmbH & Co Generica KG |
Sitagliptin Heumann 25 mg Filmtabletten |
EU |
|
Heumann Pharma GmbH & Co Generica KG |
2020-12-14 |
Diabetes Mellitus, Type 1; Parkinson Disease; Diabetic Nephropathies |
Details
|
Sitagliptin Hydrochloride |
|
Approved |
Laboratorios Alter Sa |
|
Spain |
Diabetes Mellitus, Type 2 |
Laboratorios Alter Sa |
2019-03-06 |
Diabetes Mellitus, Type 2; Polycystic Ovary Syndrome |
Details
|
Gemigliptin |
|
Approved |
|
|
|
|
|
|
|
Details
|
Linagliptin/Metformin Hydrochloride |
GC2129A; GC-2129-A; DW6013 |
Approved |
Boehringer Ingelheim Gmbh |
Jentadueto Xr, Trajenta Duo, Jentadueto, 欧双宁 |
United States |
Diabetes Mellitus, Type 2 |
Boehringer Ingelheim Gmbh |
2012-01-30 |
Diabetes Mellitus, Type 2 |
Details
|
Linagliptin/Empagliflozin |
BI 1356/BI 10773; BI 10773/linagliptin; BI 1356/empagliflozin; Empagliflozin/BI 1356; Linagliptin/BI 10773; BI 10773/BI 1356 |
Approved |
C.H. Boehringer Sohn Ag & Co. Kg |
Tradiance, Glyxambi, Esgliteo |
United States |
Diabetes Mellitus, Type 2 |
Boehringer Ingelheim Gmbh |
2015-01-30 |
Diabetes Mellitus, Type 2; Cardiovascular Diseases |
Details
|
Vildagliptin |
LAF-237; DSP-7238; LAF-237A; NVP-LAF-237 |
Approved |
Novartis Pharma Ag |
佳维乐, Equa, Jalra, Galvus, Gliptus, Xiliarx |
EU |
Diabetes Mellitus, Type 2 |
Novartis Europharm Ltd |
2007-09-25 |
Prediabetic State; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Renal Insufficiency; Schizophrenia; Kidney Diseases; Insulin Resistance; Dyslipidemias; Diabetes, Gestational; Diabetes Mellitus |
Details
|
Saxagliptin Hydrochloride/Metformin Hydrochloride |
|
Approved |
Astrazeneca Plc |
安立格, Kombiglyze Xr, Komboglyze |
EU |
Diabetes Mellitus, Type 2 |
Astrazeneca Ab |
2010-11-05 |
Diabetes Mellitus, Type 2 |
Details
|
Gemigliptin L-tartrate Sesquihydrate |
LC-150444; LC-15-0444 |
Approved |
Lg Life Sciences Ltd |
Gemiglo, Zemiglo |
South Korea |
Diabetes Mellitus, Type 2 |
Lg Life Sciences Ltd |
2012-06-27 |
Diabetes Mellitus, Type 2; Hepatic Insufficiency |
Details
|
Gemigliptin L-tartrate Sesquihydrate/Metformin Hydrochloride |
|
Approved |
Lg Life Sciences Ltd |
ZemiMet SR |
South Korea |
Diabetes Mellitus, Type 2 |
Lg Life Sciences Ltd |
2015-01-01 |
Diabetes Mellitus, Type 2 |
Details
|
Teneligliptin Hydrobromide Hydrate/Metformin Hydrochloride |
|
Approved |
Handok Inc |
Tenelia M SR |
South Korea |
Diabetes Mellitus, Type 2 |
Handok Inc |
2015-11-03 |
Diabetes Mellitus, Type 2 |
Details
|
Evogliptin |
DA-1229 |
Approved |
Dong-A Pharmaceutical Co Ltd |
Suganon, Sugarnon |
South Korea |
Diabetes Mellitus, Type 2 |
Dong-A Pharmaceutical Co Ltd |
2015-10-02 |
Diabetes Mellitus, Type 2; Kidney Diseases; Aortic valve diseases; Liver Diseases |
Details
|
Saxagliptin Hydrate |
BMS-477118; BMS-477118-11; OPC-262 |
Approved |
Bristol-Myers Squibb Company |
安立泽, Onglyza |
EU |
Diabetes Mellitus, Type 2 |
Astrazeneca Ab |
2009-07-31 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Hypoglycemia; Diabetes Mellitus |
Details
|
Teneligliptin Hydrobromide Hydrate |
MP-513 |
Approved |
Mitsubishi Tanabe Pharma |
Tenelia, Tenglyn |
Japan |
Diabetes Mellitus, Type 2 |
Mitsubishi Tanabe Pharma, Daiichi Sankyo Co Ltd |
2012-06-29 |
Diabetes Mellitus, Type 2 |
Details
|
Retagliptin Phosphate |
SP-2086 Phosphate |
Approved |
Jiangsu Hengrui Medicine Co Ltd |
瑞泽唐 |
Mainland China |
Diabetes Mellitus, Type 2 |
Jiangsu Hengrui Medicine Co Ltd |
2023-06-27 |
Diabetes Mellitus, Type 2; Renal Insufficiency; Diabetes Mellitus |
Details
|
Sitagliptin Phosphate Monohydrate/Ipragliflozin L-Proline |
MK-0431J |
Approved |
Merck & Co Inc, Astellas Pharma Inc |
Sujanu |
Japan |
Diabetes Mellitus, Type 2 |
null |
2018-03-23 |
Diabetes Mellitus, Type 2 |
Details
|
Linagliptin |
BI-1356; BI-1356-BS |
Approved |
Boehringer Ingelheim Gmbh |
欧唐宁, Ondero, Trajenta, Trayenta, Trazenta, Tradjenta |
United States |
Diabetes Mellitus, Type 2 |
Boehringer Ingelheim Gmbh |
2011-05-02 |
Prediabetic State; Diabetes Mellitus, Type 2; Albuminuria; Renal Insufficiency; Schizophrenia; Respiratory Tract Diseases; Coronavirus Disease 2019 (COVID-19); Hypertension; Endocrine System Diseases; Coronavirus Infections; Metabolic Diseases; Hepatic Insufficiency; Glucose Metabolism Disorders; Inflammation; Diabetes Mellitus; Ventricular Dysfunction, Left |
Details
|
Rosuvastatin Calcium/Gemigliptin L-tartrate Sesquihydrate |
|
Approved |
Lg Life Sciences Ltd |
ZemiStatin |
|
|
|
|
Diabetes Mellitus, Type 2; Dyslipidemias |
Details
|
Alogliptin Benzoate |
SYR-322; TAK-322 |
Approved |
Takeda |
Nesina, 尼欣那, Vipidia |
Japan |
Diabetes Mellitus, Type 2 |
Takeda |
2010-04-06 |
Diabetes Mellitus, Type 2; Acute Coronary Syndrome; Diabetes Mellitus |
Details
|
Empagliflozin/Linagliptin/Metformin |
|
Approved |
Boehringer Ingelheim Gmbh, Eli Lilly And Company |
Trijardy XR |
United States |
Diabetes Mellitus, Type 2 |
Boehringer Ingelheim Gmbh |
2020-01-27 |
Diabetes Mellitus, Type 2 |
Details
|
Sitagliptin Phosphate/Metformin Hydrochloride |
|
Approved |
Merck & Co Inc |
Velmetia, Janumet, 捷诺达, Zituvimet |
United States |
Diabetes Mellitus, Type 2 |
Merck & Co Inc |
2007-03-30 |
Diabetes Mellitus, Type 2 |
Details
|
Teneligliptin Hydrobromide Hydrate/Canagliflozin Hemihydrate |
|
Approved |
Mitsubishi Tanabe Pharma Corp, Daiichi Sankyo Co Ltd |
Canalia |
Japan |
Diabetes Mellitus, Type 2 |
Daiichi Sankyo Co Ltd, Mitsubishi Tanabe Pharma |
2017-07-03 |
Diabetes Mellitus, Type 2 |
Details
|
Anagliptin/Metformin Hydrochloride |
SK-1501 |
Approved |
Sanwa Kagaku Kenkyusho Co Ltd, Suzuken |
Metoana |
Japan |
Diabetes Mellitus, Type 2 |
Sanwa Kagaku Kenkyusho Co Ltd |
2018-09-21 |
Diabetes Mellitus, Type 2 |
Details
|
Vildagliptin/Metformin Hydrochloride |
LMF-237 |
Approved |
Novartis Pharma Ag |
宜合瑞, Eucreas, EquMet, Zomarist, Icandra |
EU |
Diabetes Mellitus, Type 2 |
Novartis Europharm Ltd |
2007-11-14 |
Diabetes Mellitus, Type 2 |
Details
|
Alogliptin Benzoate/Metformin Hydrochloride |
CT-L01; CT-L-01 |
Approved |
Takeda Pharmaceutical Co Ltd |
Vipdomet, Inisync, Kazano |
United States |
Diabetes Mellitus, Type 2 |
Takeda Pharmaceuticals U.S.A. Inc |
2013-01-25 |
Diabetes Mellitus, Type 2 |
Details
|
Anagliptin |
SK-0403; CWP-0403 |
Approved |
Sanwa Kagaku Kenkyusho Co Ltd |
Suiny, Beskoa |
Japan |
Diabetes Mellitus, Type 2 |
null |
2012-09-28 |
Diabetes Mellitus, Type 2 |
Details
|
Dapagliflozin Propanediol Monohydrate/Saxagliptin Hydrochloride |
|
Approved |
Astrazeneca Plc |
Qtern |
EU |
Diabetes Mellitus, Type 2 |
Astrazeneca Ab |
2016-07-15 |
Diabetes Mellitus, Type 2 |
Details
|
Alogliptin Benzoate/Pioglitazone Hydrochloride |
SYR-322-4833 BL |
Approved |
Takeda Pharmaceutical Co Ltd |
Nesinaact, Oseni, Liovel, Incresync |
Japan |
Diabetes Mellitus, Type 2 |
Takeda |
2011-07-01 |
Diabetes Mellitus, Type 2 |
Details
|
Sitagliptin Phosphate Monohydrate |
ONO-5435A; ONO-5435; MK-0431; MK-431; L-000224715 |
Approved |
Merck Sharp & Dohme Corp |
Ristaben, Xelevia, Tesavel, Glactiv, 捷诺维, Januvia, DIABIT-IS X |
United States |
Diabetes Mellitus, Type 2 |
Merck & Co Inc |
2006-10-16 |
Gastroparesis; Carcinoma, Hepatocellular; Hyperlipidemias; Kidney Failure, Chronic; Diabetes Mellitus; Inflammation; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Renal Insufficiency, Chronic; Cardiovascular Diseases; Hepatic Insufficiency; Hepatitis C; Psoriasis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Cystic Fibrosis; Insulin Resistance; Coronavirus Disease 2019 (COVID-19); Myelodysplastic Syndromes; Graft vs Host Disease; Glucose Intolerance; Atherosclerosis; Metabolic Dysfunction-Associated Steatotic Liver Disease; Diabetes Mellitus, Type 2; Heart Failure; HIV Infections; Prediabetic State; Diabetes Mellitus, Type 1; Leukemia, Myelogenous, Chronic |
Details
|
Trelagliptin Succinate |
TAK-472; SYR-472; SYR-111472; SYR-111472 succinate |
Approved |
Takeda Pharmaceutical Co Ltd |
Zafatek |
Japan |
Diabetes Mellitus, Type 2 |
Takeda |
2015-03-26 |
Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Evogliptin Tartrate/Metformin Hydrochloride |
DA-1229_01 |
Approved |
Dong-A Pharmaceutical Co Ltd |
Sugamet XR |
South Korea |
Diabetes Mellitus, Type 2 |
Dong-A Pharmaceutical Co Ltd |
2015-12-01 |
Diabetes Mellitus, Type 2 |
Details
|
Sitagliptin/Ertugliflozin |
|
Approved |
Pfizer Inc |
Steglujan |
United States |
Diabetes Mellitus, Type 2 |
Merck & Co Inc |
2017-12-19 |
Diabetes Mellitus, Type 2 |
Details
|
Omarigliptin |
MK-3102 |
Approved |
Merck & Co Inc |
Marizev |
Japan |
Diabetes Mellitus, Type 2 |
Merck Sharp & Dohme Corp |
2015-09-28 |
Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic; Diabetes Mellitus |
Details
|
Teneligliptin/Pioglitazone |
|
Approved |
Glenmark Pharmaceuticals Ltd |
Zita Plus Pio |
India |
Diabetes Mellitus, Type 2 |
Glenmark Pharmaceuticals Ltd |
2022-04-25 |
Diabetes Mellitus, Type 2 |
Details
|
Metformin Hydrochloride/Sitagliptin Hydrochloride |
|
Approved |
Sandoz Bv |
|
EU |
|
Sandoz Bv |
2019-12-10 |
Diabetes Mellitus, Type 2 |
Details
|
Sitagliptin Tartrate |
|
Approved |
Heumann Pharma GmbH & Co Generica KG |
Sitagliptin Heumann 25 mg Filmtabletten |
EU |
|
Heumann Pharma GmbH & Co Generica KG |
2020-12-14 |
Diabetes Mellitus, Type 1; Parkinson Disease; Diabetic Nephropathies |
Details
|
Sitagliptin Hydrochloride |
|
Approved |
Laboratorios Alter Sa |
|
Spain |
Diabetes Mellitus, Type 2 |
Laboratorios Alter Sa |
2019-03-06 |
Diabetes Mellitus, Type 2; Polycystic Ovary Syndrome |
Details
|
Gemigliptin |
|
Approved |
|
|
|
|
|
|
|
Details
|
Linagliptin/Metformin Hydrochloride |
GC2129A; GC-2129-A; DW6013 |
Approved |
Boehringer Ingelheim Gmbh |
Jentadueto Xr, Trajenta Duo, Jentadueto, 欧双宁 |
United States |
Diabetes Mellitus, Type 2 |
Boehringer Ingelheim Gmbh |
2012-01-30 |
Diabetes Mellitus, Type 2 |
Details
|
Linagliptin/Empagliflozin |
BI 1356/BI 10773; BI 10773/linagliptin; BI 1356/empagliflozin; Empagliflozin/BI 1356; Linagliptin/BI 10773; BI 10773/BI 1356 |
Approved |
C.H. Boehringer Sohn Ag & Co. Kg |
Tradiance, Glyxambi, Esgliteo |
United States |
Diabetes Mellitus, Type 2 |
Boehringer Ingelheim Gmbh |
2015-01-30 |
Diabetes Mellitus, Type 2; Cardiovascular Diseases |
Details
|
Vildagliptin |
LAF-237; DSP-7238; LAF-237A; NVP-LAF-237 |
Approved |
Novartis Pharma Ag |
佳维乐, Equa, Jalra, Galvus, Gliptus, Xiliarx |
EU |
Diabetes Mellitus, Type 2 |
Novartis Europharm Ltd |
2007-09-25 |
Prediabetic State; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Renal Insufficiency; Schizophrenia; Kidney Diseases; Insulin Resistance; Dyslipidemias; Diabetes, Gestational; Diabetes Mellitus |
Details
|
Saxagliptin Hydrochloride/Metformin Hydrochloride |
|
Approved |
Astrazeneca Plc |
安立格, Kombiglyze Xr, Komboglyze |
EU |
Diabetes Mellitus, Type 2 |
Astrazeneca Ab |
2010-11-05 |
Diabetes Mellitus, Type 2 |
Details
|